Table 2. Distributions of patients with HBV-related acute liver failure (ALFs) and asymptomatic HBV carriers (AsCs) according to the qualitative categories of AR CAG repeats.

	S-CAG allele (repeat numbers <19)	M-CAG allele (repeat numbers 19–20)	L-CAG allele (repeat numbers >20)	p values
AsCs, n (%)	234 (53.1)	106 (24.0)	101 (22.9)
ALFs, n (%)	120 (31.8)	149 (39.4)	109 (28.8)	2.4×10−9
LC-ALFs, n (%)*	49 (27.4)	80 (44.7)	50 (27.9)	6.1×10−9
NLC-ALFs, n (%)*	71 (35.7)	69 (34.7)	59 (29.6)	2.2×10−4
OR (95% CI)	1.0 (reference)	3.0 (2.1–4.2)	2.3 (1.6–3.3)	1.3×10−9

LC-ALFs, ALF patients with liver cirrhosis. NLC-ALFs, ALF patients without liver cirrhosis.